Log in
Enquire now

List of Palo Alto Investors (company) patents

List of Palo Alto Investors (company) patents
List of iRhythm Technologies patents
List of Identification International patents
List of Mentor Graphics patents
Investors in ShapeShift
List of awards received by Troye Sivan
Patents where
Current Assignee
Name
is
Palo Alto Investors (company)Palo Alto Investors (company)
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7149574 Treatment of conditions through electrical modulation of the autonomic nervous system

Patent 7149574 was granted and assigned to Palo Alto Investors (company) on December, 2006 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7149574
December 12, 2006
‌
US Patent 7363076 Treatment of conditions through modulation of the autonomic nervous system

Patent 7363076 was granted and assigned to Palo Alto Investors (company) on April, 2008 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7363076
April 22, 2008
‌
US Patent 11338120 Methods and devices for treating parasympathetic bias mediated conditions

Patent 11338120 was granted and assigned to Palo Alto Investors (company) on May, 2022 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11338120
May 24, 2022
‌
US Patent 7899527 Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase

Patent 7899527 was granted and assigned to Palo Alto Investors (company) on March, 2011 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7899527
March 1, 2011
‌
US Patent 7676269 Treatment of female fertility conditions through modulation of the autonomic nervous system

Patent 7676269 was granted and assigned to Palo Alto Investors (company) on March, 2010 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7676269
March 9, 2010
‌
US Patent 8121690 Treatment of female fertility conditions through modulation of the autonomic nervous system

Patent 8121690 was granted and assigned to Palo Alto Investors (company) on February, 2012 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8121690
February 21, 2012
‌
US Patent 9821003 Methods and devices for treating conditions associated with autonomic dysfunction

Patent 9821003 was granted and assigned to Palo Alto Investors (company) on November, 2017 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9821003
November 21, 2017
‌
US Patent 9326887 Methods and devices for treating conditions associated with autonomic dysfunction

Patent 9326887 was granted and assigned to Palo Alto Investors (company) on May, 2016 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9326887
May 3, 2016
‌
US Patent 7738952 Treatment of conditions through modulation of the autonomic nervous system

Patent 7738952 was granted and assigned to Palo Alto Investors (company) on June, 2010 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7738952
June 15, 2010
‌
US Patent 11382513 Methods and compositions for treating a condition in a subject

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11382513
July 12, 2022
‌
US Patent 8247450 Linoleic acid active agents for enhancing probability of becoming pregnant

Patent 8247450 was granted and assigned to Palo Alto Investors (company) on August, 2012 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8247450
August 21, 2012
‌
US Patent 8491459 Expandable vessel harness for treating vessel aneurysms

Patent 8491459 was granted and assigned to Palo Alto Investors (company) on July, 2013 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8491459
July 23, 2013
‌
US Patent 7767713 Linoleic acid active agents for enhancing probability of becoming pregnant

Patent 7767713 was granted and assigned to Palo Alto Investors (company) on August, 2010 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7767713
August 3, 2010
‌
US Patent 8691877 Methods and compositions for treating a disease condition in a subject

Patent 8691877 was granted and assigned to Palo Alto Investors (company) on April, 2014 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8691877
April 8, 2014
‌
US Patent 11383084 Treatment of dermatological conditions via neuromodulation

Patent 11383084 was granted and assigned to Palo Alto Investors (company) on July, 2022 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11383084
July 12, 2022
‌
US Patent 7966072 Methods and compositions for treating obesity-hypoventilation syndrome

Patent 7966072 was granted and assigned to Palo Alto Investors (company) on June, 2011 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7966072
June 21, 2011
‌
US Patent 8722016 Methods of identifying xenohormetic phenotypes and agents

Patent 8722016 was granted and assigned to Palo Alto Investors (company) on May, 2014 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8722016
May 13, 2014
‌
US Patent 11480562 Methods of identifying xenohormetic phenotypes and agents

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11480562
October 25, 2022
‌
US Patent 11389534 Methods of treating a subject for a condition

Patent 11389534 was granted and assigned to Palo Alto Investors (company) on July, 2022 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11389534
July 19, 2022
‌
US Patent 8788041 Methods and compositions for treating a disease condition in a subject

Patent 8788041 was granted and assigned to Palo Alto Investors (company) on July, 2014 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8788041
July 22, 2014
‌
US Patent 10426950 Methods and devices for treating parasympathetic bias mediated conditions

Patent 10426950 was granted and assigned to Palo Alto Investors (company) on October, 2019 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10426950
October 1, 2019
‌
US Patent 11179423 Methods of enhancing female fertility

Patent 11179423 was granted and assigned to Palo Alto Investors (company) on November, 2021 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11179423
November 23, 2021
‌
US Patent 8909340 Methods and devices for treating conditions associated with autonomic dysfunction

Patent 8909340 was granted and assigned to Palo Alto Investors (company) on December, 2014 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8909340
December 9, 2014
‌
US Patent 11020051 Methods of enhancing homeostatic capacity in a subject by modulating homeostatic system synchrony, and devices for use in practicing the same

Patent 11020051 was granted and assigned to Palo Alto Investors (company) on June, 2021 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11020051
June 1, 2021
‌
US Patent 9320894 Methods and compositions for treating a renal associated condition in a subject

Patent 9320894 was granted and assigned to Palo Alto Investors (company) on April, 2016 by the United States Patent and Trademark Office.

Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
Palo Alto Investors (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9320894
April 26, 2016
Results per page:
45 results
0 selected
45 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us